Interestingly, TACE combined verteporfin significantly improved the outcomes and prognosis of transplanted HCC compared with the TACE group, suggested that inhibiting the Hippo/YAP signaling pathway could significantly improve the outcomes of TACE in treating transplanted HCC. Here, YAP1 is linked to hepatocellular carcinoma.